Microarray analysis of ovarian cancer

Conference Proceedings - IEEE International Conference on Systems, Man and Cybernetics

Volumn 2, Issue , 2005, Pages 1036-1041

  Huang, G Steven ^a   Hung, Yao Ching ^b   Chen, Ann ^c   Hong, Meng Yen ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Early diagnostic marker; Gene expression; Microarray; Ovarian cancer

Indexed keywords

ARRAYS; BIOMARKERS; CARCINOGENS; DIAGNOSIS; GENES; GENETIC ENGINEERING; TUMORS;

EARLY DIAGNOSTIC MARKERS; GENE EXPRESSIONS; MICROARRAYS; OVARIAN CANCER;

ONCOLOGY;

EID: 27944456056     PISSN: 1062922X     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (25)

1. A. Jemal, A. Thomas, T. Murray and M. Thun, "Cancer statistics, 2002," CA Cancer J Clin, Vol 52, No. 1, pp. 23-47, 2002.
2. J.S. Berek and R.C. Bast Jr., "Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection," Cancer, Vol 76, No. 10, Supp 1, pp. 2092-6, 1995.
3. M. Schena, D. Shalon, R.W. Davis and P.O. Brown, "Quantitative monitoring of gene expression patterns with a complementary DNA microarray," Science, Vol 270, No. 5235, pp. 467-70, 1995.
4. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, et al., "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling," Nature, Vol 403, No. 6769, pp. 503-11, 2000.
5. J. DeRisi, L. Penland, P.O. Brown, M.L. Bittner, P.S. Meltzer, M. Ray, et al., "Use of a cDNA microarray to analyse gene expression patterns in human cancer," Nat Genet, Vol 14, No. 4, pp. 457-60, 1996.
6. M. Schummer, W.V. Ng, R.E. Bumgarner, P.S. Nelson, B. Schummer, D.W. Bednarski, et al., "Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas," Gene, Vol 238, No. 2, pp. 375-85, 1999.
7. K. Wang, L. Gan, E. Jeffery, M. Gayle, A.M. Gown, M. Skelly, et al., "Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray," Gene, Vol 229, No. 1-2, pp. 101-8, 1999.
8. R.S. Ismail, R.L. Baldwin, J. Fang, D. Browning, B.Y. Karlan, J.C. Gasson, et al., "Differential gene expression between normal and tumor-derived ovarian epithelial cells," Cancer Res, Vol 60, No. 23, pp. 6744-9, 2000.
9. A.M. Martoglio, B.D. Tom, M. Starkey, A.N. Corps, D.S. Charnock-Jones and S.K. Smith, "Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays," Mol Med, Vol 6, No. 9, pp. 750-65, 2000.
10. K. Ono, T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, A. Okamoto, et al., "Identification by cDNA microarray of genes involved in ovarian carcinogenesis," Cancer Res, Vol 60, No. 18, pp. 5007-11, 2000.
11. J.B. Welsh, P.P. Zarrinkar, L.M. Sapinoso, S.G. Kern, C.A. Behling, B.J. Monk, et al., "Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer," Proc Natl Acad Sci USA, Vol 98, No. 3, pp. 1176-81, 2001.
12. S. Pecorelli, F. Odicino, P. Maisonneuve, W. Creasman, J. Shepherd, M. Sideri, et al., "Carcinoma of the ovary. Annual report on the results of treatment of gynecological cancer, vol 23. International Federation of Gynecology and Obstetrics," J Epidemiol Biostat, Vol 3, pp. 75-102, 1998.
13. A. Brazma, P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, et al., "Minimum information about a microarray experiment (MIAME)-toward standards for microarray data," Nat Genet, Vol 29, No. 4, pp. 365-71, 2001.
14. K.K. Wong, R.S. Cheng, and S.C. Mok, "Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system," Biotechniques, Vol 30, No. 3, pp. 670-5, 2001.
15. S.M. Jacobs-Helber, R.M. Abutin, C. Tian, M. Bondurant, A. Wickrema and S.T. Sawyer, "Role of JunB in erythroid differentiation," J Biol Chem, Vol 277, No. 7, pp. 4859-66, 2002.
16. Y.F. Hu and R. Li, "JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction," Genes Dev, Vol 16, No. 12, pp. 1509-17, 2002.
17. A.R. Gunthert, C. Grundker, K. Hollmann and G. Emons, "Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells," Biochem Biophys Res Commun, Vol 294, No. 1, pp. 11-5, 2002.
18. A. Velazquez Torres and P. Gariglio Vidal, "Possible role of transcription factor API in the tissue-specific regulation of human papillomavirus," Rev Invest Clin, Vol 54, No. 3, pp. 231-42, 2002.
19. R. Rusovici and H.A. LaVoie, "Expression and distribution of AP-1 transcription factors in the porcine ovary," Biol Reprod, Vol 69, No. 1, pp. 64-74, 2003.
20. S. Baumann, J. Hess, S.T. Eichhorst, A. Krueger, P. Angel, P.H. Krammer and S. Kirchhoff, "An unexpected role for FosB in activation-induced cell death of T cells," Oncogene, Vol 22, No. 9, pp. 1333-9, 2003.
21. B. Neyns, Katesuwanasing, J. Vermeij, C. Bourgain, B. Vandamme, K. Amfo, W. Lissens, P. DeSutter, E. Hooghe-Peters and J. DeGreve, "Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium," Oncogene, Vol 12, No. 6, pp. 1247-57, 1996.
22. B. Neyns, E. Teugels, C. Bourgain, M. Birrerand and J. De Greve, "Alteration of jun proto-oncogene status by plasmid transfection affects growth of human ovarian cancer cells," Int J Cancer, Vol 82, No. 5, pp. 687-93, 1999.
23. S. Cory and J.M. Adams, "The Bc12 family: regulators of the cellular life-or-death switch," Nat Rev Cancer, Vol 2, No. 9, pp. 647-56, 2002.
24. D. Boerboom, N. Pilon, R. Behdjani, D.W. Silversides, J. Sirois, S.I. Karchner, et al., "Expression and regulation of transcripts encoding two members of the NR5A nuclear receptor subfamily of orphan nuclear receptors, steroidogenic factor-1 and NR5A2, in equine ovarian cells during the ovulatory process," Endocrinology, Vol 141, No. 12, pp. 4647-56, 2000.
25. C. Laflamme, C. Filion, J.A. Bridge, M. Ladanyi, M.B. Goldring and Y. Labelle, "The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas," Cancer Res, Vol 63, No. 2, pp. 449-54, 2003.